BCHE and Alzheimer disease: Disease-modifying therapy (DMT) has been widely used in recent decades as an effective disease-modifying therapy to treat NDs (Gross and Corboy, 2019; Cole et al., 2021), and there are now two approved drugs used to treat AD, namely, cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) antagonists.